DaVita Kidney Care expands care of kidney patients in Malaysia

DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced it acquired three hemodialysis centers from Malaysian dialysis provider Sinar Indentiti Sbn Bhd, further expanding its care of kidney patients in the country.

"DaVita is committed to raising the standard of care for chronic kidney disease patients in Malaysia," said Atul Mathur, president of DaVita Kidney Care in the Asia-Pacific region. "As we continue to seek opportunities to bring DaVita's industry-leading outcomes to chronic kidney disease populations in the country, we believe Malaysia's kidney patients ultimately benefit."

The acquisition adds three clinics to DaVita's 21 existing centers, which span both peninsular and east Malaysia.

In Malaysia, kidney disease is a growing health concern. According to the Malaysian Society of Nephrology, more than 30,000 patients receive life-sustaining dialysis treatments, a population that has grown nearly 12 percent year over year.

"Southeast Asia's growing population is resulting in an increase of patients suffering from chronic kidney disease," said Dr. Gan Wee Hin, a nephrologist with Sinar Indentiti who is staying on as clinic medical director with DaVita. "I strongly believe by joining DaVita – an organization that has vast experience and an impressive record all over the world – we can improve clinical outcomes in our group of patients."

DaVita has improved clinical outcomes each year since 2000 in the United States and has consistently demonstrated clinical results that are the best or among the best in virtually every category in the kidney care industry. These outcomes help drive lower mortality rates and fewer hospitalizations, results that DaVita brings to clinics around the world to improve patients' health and quality of life.

SOURCE DaVita Inc.